SEC Tracker
Get the app

VYNE Therapeutics YARW

Citadel Advisors updates its stake in VYNE Therapeutics

Form
Schedule 13G/A
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by CITADEL ADVISORS LLC (amended)

View on EDGAR

Open in the app

Get an email when VYNE Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  2. Insight Molecular Diagnostics IMDX public float $32M, Jun 30, 2025
  3. Kezar Life Sciences KZR public float $33M, Jun 30, 2025
  4. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  5. Tempest Therapeutics TPST public float $30M, Jun 30, 2025